| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
CKIepsilon/delta-dependent phosphorylation is a temperature-insensitive, period-determining process in the mammalian circadian clock.
|
Proc Natl Acad Sci U S A
|
2009
|
1.73
|
|
2
|
A randomized, placebo-controlled clinical trial of tacrolimus ophthalmic suspension 0.1% in severe allergic conjunctivitis.
|
J Ocul Pharmacol Ther
|
2010
|
1.12
|
|
3
|
Japanese guideline for allergic conjunctival diseases.
|
Allergol Int
|
2011
|
1.10
|
|
4
|
Application of visante optical coherence tomography tear meniscus height measurement in the diagnosis of dry eye disease.
|
Ophthalmology
|
2010
|
1.07
|
|
5
|
Atopic ocular surface disease: implications on tear function and ocular surface mucins.
|
Cornea
|
2005
|
1.04
|
|
6
|
Early visual results with the rollable ThinOptX intraocular lens.
|
J Cataract Refract Surg
|
2004
|
0.99
|
|
7
|
Conjunctival in vivo confocal scanning laser microscopy in patients with atopic keratoconjunctivitis.
|
Mol Vis
|
2007
|
0.96
|
|
8
|
The relation of conjunctival and corneal findings in severe ocular allergies.
|
Cornea
|
2004
|
0.96
|
|
9
|
The implications of the upregulation of ICAM-1/VCAM-1 expression of corneal fibroblasts on the pathogenesis of allergic keratopathy.
|
Invest Ophthalmol Vis Sci
|
2005
|
0.95
|
|
10
|
Disposable eyelid-warming device for the treatment of meibomian gland dysfunction.
|
Jpn J Ophthalmol
|
2003
|
0.94
|
|
11
|
Early visual results with the 1CU accommodating intraocular lens.
|
J Cataract Refract Surg
|
2005
|
0.93
|
|
12
|
Regulation of prostaglandin endoperoxide synthase-2 and IL-6 expression in mouse bone marrow-derived mast cells by exogenous but not endogenous prostanoids.
|
J Immunol
|
2002
|
0.91
|
|
13
|
Blood level of tacrolimus in patients with severe allergic conjunctivitis treated by 0.1% tacrolimus ophthalmic suspension.
|
Allergol Int
|
2012
|
0.90
|
|
14
|
TGF-beta1, IL-1beta, and Th2 cytokines stimulate vascular endothelial growth factor production from conjunctival fibroblasts.
|
Exp Eye Res
|
2005
|
0.90
|
|
15
|
Ocular surface and MUC5AC alterations in atopic patients with corneal shield ulcers.
|
Curr Eye Res
|
2005
|
0.89
|
|
16
|
In vivo confocal microscopy evaluation of meibomian gland dysfunction in atopic-keratoconjunctivitis patients.
|
Ophthalmology
|
2012
|
0.89
|
|
17
|
Evaluation of conjunctival inflammatory status by confocal scanning laser microscopy and conjunctival brush cytology in patients with atopic keratoconjunctivitis (AKC).
|
Mol Vis
|
2009
|
0.87
|
|
18
|
The impact of the onset time of atopic keratoconjunctivitis on the tear function and ocular surface findings.
|
Am J Ophthalmol
|
2006
|
0.86
|
|
19
|
Evaluation of lipid oxidative stress status and inflammation in atopic ocular surface disease.
|
Mol Vis
|
2010
|
0.86
|
|
20
|
Comparison of 0.1% bromfenac sodium and 0.1% pemirolast potassium for the treatment of allergic conjunctivitis.
|
Jpn J Ophthalmol
|
2004
|
0.84
|
|
21
|
Tryptase increases proliferative activity of human conjunctival fibroblasts through protease-activated receptor-2.
|
Invest Ophthalmol Vis Sci
|
2005
|
0.84
|
|
22
|
Corneal in vivo confocal scanning laser microscopy in patients with atopic keratoconjunctivitis.
|
Ophthalmology
|
2008
|
0.84
|
|
23
|
Dramatic healing of an allergic corneal ulcer persistent for 6 months by amniotic membrane patching in a patient with atopic keratoconjunctivitis: a case report.
|
Cornea
|
2004
|
0.83
|
|
24
|
Tear film lipid layer alterations in allergic conjunctivitis.
|
Cornea
|
2006
|
0.82
|
|
25
|
A large prospective observational study of novel cyclosporine 0.1% aqueous ophthalmic solution in the treatment of severe allergic conjunctivitis.
|
J Ocul Pharmacol Ther
|
2009
|
0.82
|
|
26
|
Quantitative evaluation of eyelid elasticity using the cutometer SEM575 and its clinical application in assessing the efficacy of tacrolimus ointment treatment in eyelid atopic dermatitis.
|
Cornea
|
2004
|
0.81
|
|
27
|
Participation of cytosolic phospholipase A2 in eicosanoid generation by mouse bone marrow-derived mast cells.
|
Adv Exp Med Biol
|
2002
|
0.79
|
|
28
|
Efficacy of levocabastine hydrochloride ophthalmic suspension in the conjunctival allergen challenge test in Japanese subjects with seasonal allergic conjunctivitis.
|
Allergol Int
|
2006
|
0.79
|
|
29
|
Corneal and conjunctival fibroblasts are major sources of eosinophil-recruiting chemokines.
|
Allergol Int
|
2009
|
0.79
|
|
30
|
A comparative evaluation of the efficacy of intraoperative mitomycin C use after the excision of cobblestone-like papillae in severe atopic and vernal keratoconjunctivitis.
|
Cornea
|
2004
|
0.78
|
|
31
|
Functional visual acuity assessment of severe atopic keratoconjunctivitis.
|
Cornea
|
2014
|
0.78
|
|
32
|
Suppressive effects of tranilast on eotaxin-1 production from cultured conjunctival fibroblasts.
|
Curr Eye Res
|
2008
|
0.78
|
|
33
|
OCT assessment of tear meniscus after punctal occlusion in dry eye disease.
|
Optom Vis Sci
|
2012
|
0.78
|
|
34
|
[A prospective, observational, all-prescribed-patients study of cyclosporine 0.1% ophthalmic solution in the treatment of vernal keratoconjunctivitis].
|
Nippon Ganka Gakkai Zasshi
|
2011
|
0.78
|
|
35
|
Visante optical coherence tomography and tear function test evaluation of cholinergic treatment response in patients with sjögren syndrome.
|
Cornea
|
2013
|
0.78
|
|
36
|
IgE and eosinophil cationic protein (ECP) as markers of severity in the diagnosis of atopic keratoconjunctivitis.
|
Br J Ophthalmol
|
2012
|
0.77
|
|
37
|
CC-chemokine receptor 3: a possible target in treatment of allergy-related corneal ulcer.
|
Invest Ophthalmol Vis Sci
|
2002
|
0.77
|
|
38
|
Mechanisms of giant papillary formation in vernal keratoconjunctivitis.
|
Cornea
|
2006
|
0.77
|
|
39
|
Quantitative evaluation of the early changes in ocular surface inflammation following MMC-aided papillary resection in severe allergic patients with corneal complications.
|
Cornea
|
2006
|
0.76
|
|
40
|
Successful topical application of a new antifungal agent, micafungin, in the treatment of refractory fungal corneal ulcers: report of three cases and literature review.
|
Cornea
|
2005
|
0.76
|
|
41
|
Elevated levels of human alpha -defensin in tears of patients with allergic conjunctival disease complicated by corneal lesions: detection by SELDI ProteinChip system and quantification.
|
Curr Eye Res
|
2005
|
0.76
|
|
42
|
Eosinophil cationic protein as a marker for assessing the efficacy of tacrolimus ophthalmic solution in the treatment of atopic keratoconjunctivitis.
|
Mol Vis
|
2011
|
0.75
|
|
43
|
Kaposi varicelliform eruption associated with 0.1% tacrolimus ointment treatment in atopic blepharitis.
|
Cornea
|
2004
|
0.75
|
|
44
|
Naphthol derivatives as TRPV1 inhibitors for the treatment of urinary incontinence.
|
Bioorg Med Chem Lett
|
2011
|
0.75
|
|
45
|
[Evaluation of the efficacy of subjective symptoms, objective findings, and of a total tear IgE detection kit in diagnosis of allergic conjunctival diseases].
|
Nippon Ganka Gakkai Zasshi
|
2012
|
0.75
|
|
46
|
Tetrahydro-naphthols as orally available TRPV1 inhibitors.
|
Bioorg Med Chem Lett
|
2012
|
0.75
|
|
47
|
[A quality of life questionnaire for Japanese allergic conjunctival disease].
|
Nippon Ganka Gakkai Zasshi
|
2012
|
0.75
|